These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11817813)

  • 21. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics.
    Kato R; Ikeda N; Yabek SM; Kannan R; Singh BN
    J Am Coll Cardiol; 1986 Jan; 7(1):116-25. PubMed ID: 3941198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart.
    Guérard NC; Traebert M; Suter W; Dumotier BM
    J Pharmacol Toxicol Methods; 2008; 58(1):32-40. PubMed ID: 18582585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
    Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation.
    Sager PT; Behboodikhah M
    J Cardiovasc Electrophysiol; 1996 Feb; 7(2):102-12. PubMed ID: 8853020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordings.
    Shimizu W; Kurita T; Suyama K; Aihara N; Kamakura S; Shimomura K
    Am J Cardiol; 1996 May; 77(11):1004-8. PubMed ID: 8644624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle.
    Schmitt C; Brachmann J; Karch M; Waldecker B; Navarrete L; Montero M; Beyer T; Kübler W
    Am J Cardiol; 1991 Nov; 68(11):1183-7. PubMed ID: 1951078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ischemia-induced action potential shortening is blunted by d-sotalol in a pig model of reversible myocardial ischemia.
    Geelen P; O'Hara GE; Plante S; Philippon F; Gilbert M; Turgeon J
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):638-45. PubMed ID: 10774796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steady-state and dynamic behavior of ventricular repolarization and refractoriness in the dog: the effect of multiple cycle length changes and d-sotalol administration.
    Leerssen HM; Vos MA; den Dulk K; van der Zande J; Muijtjens AM; Begemann MJ; Wellens HJ
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1766-77. PubMed ID: 9744441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
    Lee SD; Newman D; Ham M; Dorian P
    J Am Coll Cardiol; 1997 Jan; 29(1):100-5. PubMed ID: 8996301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Class III antiarrhythmic action of d-sotalol during hypothermia.
    Bjørnstad H; Tande PM; Refsum H
    Am Heart J; 1991 May; 121(5):1429-36. PubMed ID: 2017975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of volume loading and load reduction on ventricular refractoriness and conduction properties in canine congestive heart failure.
    Zhu WX; Johnson SB; Brandt R; Burnett J; Packer DL
    J Am Coll Cardiol; 1997 Sep; 30(3):825-33. PubMed ID: 9283547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular electrophysiologic responses of isolated neonatal and adult cardiac fibers to d-sotalol.
    Yabek SM; Kato R; Ikeda N; Singh BN
    J Am Coll Cardiol; 1988 May; 11(5):1094-9. PubMed ID: 3356828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sotalol, aprindine and the combination aprindine-sotalol on monophasic action potential duration.
    Stroobandt R; Brachmann J; Kesteloot H; Kübler W; Senges J
    Eur Heart J; 1986 Jan; 7(1):47-53. PubMed ID: 3956522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change of atrial refractory period after short duration of rapid atrial pacing: regional differences and possible mechanisms.
    Lee SH; Chen SA; Yu WC; Cheng JJ; Kaun P; Hung CR; Chang MS; Lin FY
    Pacing Clin Electrophysiol; 1999 Jun; 22(6 Pt 1):927-34. PubMed ID: 10392391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy.
    Akar FG; Spragg DD; Tunin RS; Kass DA; Tomaselli GF
    Circ Res; 2004 Oct; 95(7):717-25. PubMed ID: 15345654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between the U wave on electrocardiogram and the midmyocardium of the left ventricular wall.
    Zhang C; Li Y; Lu Z; Wu J; Wang C
    Chin Med J (Engl); 2002 Apr; 115(4):509-12. PubMed ID: 12133285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium abolishes inadequate kinetics of frequency adaptation of the Q-aT interval in the presence of sotalol.
    Stark G; Schwarzl I; Heiden U; Stark U; Tritthart HA
    Cardiovasc Res; 1997 Jul; 35(1):43-51. PubMed ID: 9302346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans.
    Newman D; Dorian P; Feder-Elituv R
    Can J Physiol Pharmacol; 1993; 71(10-11):755-60. PubMed ID: 8143233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.